Skip to the content
REVOLUTIONIZING TREATMENT DECISIONS
Follow us on
One2Treat
  • Home
  • Solutions
    • INNOVATIVE TRIAL DESIGN
    • Inform Strategic Decisions
    • Benefit-Risk Assessment
  • Resources
    • Net Treatment Benefit
    • Press Releases
    • Regulatory submissions
    • Blogs
    • Case studies
    • Peer-reviewed papers
  • About
    • About One2Treat
    • One2Treat’s Team
    • Contact
  • Careers
Request a demo
  • Home
  • Solutions
    • INNOVATIVE TRIAL DESIGN
    • Inform Strategic Decisions
    • Benefit-Risk Assessment
  • Resources
    • Net Treatment Benefit
    • Press Releases
    • Regulatory submissions
    • Blogs
    • Case studies
    • Peer-reviewed papers
  • About
    • About One2Treat
    • One2Treat’s Team
    • Contact
  • Careers
Our resources

Case studies

  • All
  • Holistic Data Analysis
  • Innovative Trial Design
  • Market Access And HTA
  • Shared Decision Making
OSE Immunotherapeutics: One2Treat Voice for outcomes prioritization in ARTEMIA
Trial Designs
OSE Immunotherapeutics: One2Treat Voice for outcomes prioritization in ARTEMIA
READ MORE →
Benefit-risk analyses in cancer treatment
Innovative Trial Design
Benefit-risk analyses in cancer treatment
READ MORE →
Design a patient-centric trial & avoid a demonstration of “non-inferiority”
Innovative Trial Design
Design a patient-centric trial & avoid a demonstration of “non-inferiority”
READ MORE →
Using more information for fewer patients.
Innovative Trial Design
Using more information for fewer patients.
READ MORE →

Want to invest in a more holistic understanding
of net treatment benefit?


Get in touch
One2Treat footer logo

SOLUTIONS

  • Innovative Trial Design
  • Inform Strategic Decisions
  • Benefit Risk Assessment

ABOUT

  • About One2Treat
  • One2Treat’s Team
  • Contact

RESOURCES

  • Learn more about Net Treatment Benefit
  • Case studies
  • Regulatory submissions
  • PRs, podcasts & webinars
  • Scientific papers
Copyright © 2025 — One2Treat
Privacy Policy